XML 34 R20.htm IDEA: XBRL DOCUMENT v3.24.0.1
Fair Value Measurements
12 Months Ended
Dec. 31, 2023
Fair Value Disclosures [Abstract]  
Fair Value Measurements FAIR VALUE MEASUREMENTS
The Company’s financial assets and liabilities measured at fair value on a recurring basis were as follows:
As of December 31, 2023
(in thousands)Level 1Level 2Level 3Total
Assets
 
 
 
Money market investments (1) 
$ $5,577 $ $5,577 
Marketable equity securities (2) 
690,153   690,153 
Other current investments (3) 
6,875   6,875 
Total Financial Assets
$697,028 $5,577 $ $702,605 
Liabilities
 
 
 
Contingent consideration liabilities (4)
$ $ $788 $788 
Interest rate swaps (5) 
 2,761  2,761 
Foreign exchange swap (6) 
 86  86 
Mandatorily redeemable noncontrolling interest (7)
  40,764 40,764 
Total Financial Liabilities
$ $2,847 $41,552 $44,399 
As of December 31, 2022
(in thousands)Level 1Level 2Level 3Total
Assets
  
  
  
Money market investments (1) 
$— $7,686 $— $7,686 
Marketable equity securities (2) 
609,921 — — 609,921 
Other current investments (3) 
7,471 5,016 — 12,487 
Interest rate swaps (8)
— 2,636 — 2,636 
Total Financial Assets
$617,392 $15,338 $— $632,730 
Liabilities
  
  
  
Contingent consideration liabilities (4)
$— $— $8,423 $8,423 
Foreign exchange swap (6)
— 333 — 333 
Mandatorily redeemable noncontrolling interest (7)
— — 30,845 30,845 
Total Financial Liabilities
$— $333 $39,268 $39,601 
____________
(1)
The Company’s money market investments are included in cash and cash equivalents and the value considers the liquidity of the counterparty.
(2)
The Company’s investments in marketable equity securities are held in common shares of U.S. corporations that are actively traded on U.S. exchanges. Price quotes for these shares are readily available.
(3)
Includes U.S. Government Securities, corporate bonds, mutual funds and time deposits. These investments are valued using a market approach based on the quoted market prices of the security or inputs that include quoted market prices for similar instruments and are classified as either Level 1 or Level 2 in the fair value hierarchy.
(4)
Included in Accounts payable, vehicle floor plan payable and accrued liabilities and Other Liabilities. The Company determined the fair value of the contingent consideration liabilities using either a Monte Carlo simulation, Black-Scholes model, or probability-weighted analysis depending on the type of target included in the contingent consideration requirements (revenue, EBITDA, client retention). All analyses included estimated financial projections for the acquired businesses and acquisition-specific discount rates.
(5)
Included in Other Liabilities. The Company utilized a market approach model using the notional amount of the interest rate swap multiplied by the observable inputs of time to maturity and market interest rates.
(6)
Included in Accounts payable, vehicle floor plan payable and accrued liabilities, and valued based on a valuation model that calculates the differential between the contract price and the market-based forward rate.
(7)
The fair value of the mandatorily redeemable noncontrolling interest is based on the fair value of the underlying subsidiaries owned by GHC One and GHC Two, after taking into account any debt and other noncontrolling interests of its subsidiary investments. The fair value of the owned subsidiaries is determined using enterprise value analyses which include an equal weighing between guideline public company and discounted cash flow analyses.
(8)Included in Deferred Charges and Other Assets. The Company utilized a market approach model using a notional amount of the interest rate swaps multiplied by the observable inputs of time to maturity and market interest rates.
The following table provides a reconciliation of changes in the Company’s financial liabilities measured at fair value on a recurring basis, using Level 3 inputs:
(in thousands)Contingent consideration liabilitiesMandatorily redeemable noncontrolling interest
As of December 31, 2021$14,881 $13,661 
Acquisition of business397 — 
Changes in fair value (1)
(6,672)16,489 
Capital contributions
— 1,018 
Accretion of value included in net income (1)
1,567 — 
Settlements or distributions(1,750)(323)
As of December 31, 20228,423 30,845 
Acquisition of business220  
Changes in fair value (1)
(7,423)10,122 
Capital contributions
 411 
Accretion of value included in net income (1)
830  
Settlements or distributions(1,262)(614)
As of December 31, 2023$788 $40,764 
____________
(1)Changes in fair value and accretion of value of contingent consideration liabilities are included in Selling, general and administrative expenses and the changes in fair value of mandatorily redeemable noncontrolling interest is included in Interest expense in the Company’s Consolidated Statements of Operations.
For the years ended December 31, 2023, 2022 and 2021, the Company recorded goodwill and other long-lived asset impairment charges of $99.1 million, $129.0 million and $32.9 million, respectively (see Note 19). The remeasurement of goodwill and other long-lived assets is classified as a Level 3 fair value assessment due to the significance of unobservable inputs developed in the determination of the fair value. The Company used a discounted cash flow model to determine the estimated fair value of the reporting units, indefinite-lived intangible assets, and other long-lived assets. Where appropriate, a market value approach was also utilized to supplement the discounted cash flow model. The Company made estimates and assumptions regarding future cash flows, royalty rates, discount rates, market values, and long-term growth rates.
For the years ended December 31, 2023, 2022 and 2021, the Company recorded gains of $3.1 million, $6.9 million and $11.8 million, respectively, to equity securities that are accounted for as cost method investments based on observable transactions for identical or similar investments of the same issuer. For the years ended December 31, 2023 and 2022, the Company recorded impairment losses of $0.5 million and $1.3 million, respectively, to equity securities that are accounted for as cost method investments.
For the year ended December 31, 2021, the Company recorded impairment charges of $6.6 million on one of its investments in affiliates (see Note 4).